Novartis
NVS
1,118 hedge funds and large institutions have $19.7B invested in Novartis in 2020 Q3 according to their latest regulatory filings, with 77 funds opening new positions, 346 increasing their positions, 458 reducing their positions, and 73 closing their positions.
42% more call options, than puts
Call options by funds: $178M | Put options by funds: $125M
5% more first-time investments, than exits
New positions opened: 77 | Existing positions closed: 73
0.46% less ownership
Funds ownership: 9.63% → 9.17% (-0.46%)
1% less funds holding
Funds holding: 1,128 → 1,118 (-10)
5% less capital invested
Capital invested by funds: $20.7B → $19.7B (-$1.08B)
13% less funds holding in top 10
Funds holding in top 10: 15 → 13 (-2)
24% less repeat investments, than reductions
Existing positions increased: 346 | Existing positions reduced: 458
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dodge & Cox
San Francisco,
California
|
+$211M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$68.9M |
| 3 |
Mawer Investment Management
Calgary,
Alberta, Canada
|
+$49.4M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$31.1M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$29.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBHC
Brown Brothers Harriman & Co
New York
|
-$313M |
| 2 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$170M |
| 3 |
Renaissance Technologies
New York
|
-$140M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$118M |
| 5 |
FAM
Fred Alger Management
New York
|
-$108M |
NVS Hedge Fund Activity: Q3 2020 in Review
1,118 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Novartis (NVS) for Q3 2020, worth a combined $19.7B — down 5.2% from $20.7B a quarter earlier.
Buyers outnumbered sellers: 77 funds opened new NVS positions and 73 closed out — a net gain of 4 holders — while 346 added to existing stakes and 458 trimmed.
The largest buyer was Dodge & Cox, adding an estimated $211M. The largest seller was Brown Brothers Harriman & Co, cutting an estimated $313M.
- 1,118 institutional investors held Novartis (NVS) as of Q3 2020, down from 1,128 in Q2 2020.
- Funds reported $19.7B of Novartis stock for Q3 2020, down 5.2% quarter-over-quarter.
- 77 funds opened new Novartis positions in Q3 2020 and 73 closed out, a net change of +4 holders.
- The largest Novartis buyer in Q3 2020 was Dodge & Cox, an estimated $211M added.
- The largest Novartis seller in Q3 2020 was Brown Brothers Harriman & Co, an estimated $313M sold.
Based on aggregated 13F filings for Q3 2020.